Remel Inc.

Remel Inc., doing business as Thermo Fisher Scientific Remel Products, manufactures and supplies specialized microbiology laboratory products, antimicrobial susceptibility testing systems, diagnostic consumables, and reagents to federal health and research agencies as a prime contractor under full-and-open competitive and sole-source procurements. The company is a foreign-owned subsidiary of Thermo Fisher Scientific Inc., headquartered in Lenexa, Kansas, and competes predominantly as a large, established provider without small business set-aside protections across its federal footprint.

Remel's federal contract portfolio spans recent awards across civilian health agencies, with concrete capability anchoring in Sensititre antimicrobial susceptibility testing (AST) systems, blood culture media, diagnostic panels, laboratory reagents, and related consumables essential to antimicrobial resistance surveillance and food safety programs. Representative work includes a $2.5 million single-award IDIQ with the Food and Drug Administration (awarded March 21, 2022, through March 20, 2027) for Sensititre-compatible supplies supporting the National Antimicrobial Resistance Monitoring System and regulatory science initiatives, with sixteen task orders executed totaling approximately $1.14 million; a $1.25 million single-award IDIQ with Veterans Integrated Service Network 20 (awarded January 1, 2026, through December 31, 2030) for antimicrobial susceptibility testing reagents and consumables supplied on a cost-per-test basis; and a $2.36 million single-award IDIQ with the Defense Health Agency (awarded May 20, 2024, through May 21, 2029) procuring Sensititre consumables and laboratory supplies for the Walter Reed Army Institute of Research. Additionally, Remel holds a $600,000 single-award IDIQ with the Department of Agriculture's Office of Administrative Services Procurement Management Branch (awarded September 5, 2024, through September 4, 2027) for antimicrobial susceptibility testing supplies supporting NARMS and the Eastern Laboratory.

Customer concentration is pronounced and civilian-health oriented. The top five funding agencies by award count—Defense Logistics Agency Troop Support Medical, the Food and Drug Administration, CDC Pittsburgh, the Department of the Navy Bureau of Medicine and Surgery, and the Department of Agriculture's Office of Administrative Services Procurement Management Branch—account for roughly 5 percent of all awards but anchor the portfolio's dollar value. By potential value, the FDA leads with $9.7 million across 72 awards, followed by USDA at $5.4 million across 46 awards and Veterans Integrated Service Network 20 at $4.9 million across 22 awards. The concentration reflects Remel's specialization in antimicrobial resistance monitoring and diagnostic laboratory support rather than broad-based federal supply provision.

Remel's parent vehicle footprint centers on the Federal Supply Schedule (GSA schedule V797P5588X carries 4,227 task orders valued at $6.4 million combined), with secondary vehicles including an indefinite delivery contract (SPM20006D7334, 87 task orders, $384 thousand) and a blanket purchase agreement (VBPA580160041, 69 task orders, $58 thousand). The vendor does not appear to sub-award work; the source identifies Remel as a 100-percent prime contractor across its federal activity. Recent award velocity shows moderate activity, with 10 awards through September 2026 (annualized run rate lower than prior years), and 13 awards (combined potential value $1.3 million) face completion within the next twenty-four months and therefore recompete risk.

Remel's category footprint aligns with its core capabilities: the source data reflect concentration in In-Vitro Diagnostic Substance Manufacturing (NAICS 325413, 4,529 awards), Analytical Laboratory Instrument Manufacturing (NAICS 334516, 146 awards), and Medical Laboratories (NAICS 621511, 75 awards). By PSC code, In Vitro Diagnostic Substances, Reagents, Test Kits and Sets (PSC 6550, 3,369 awards) and Laboratory Equipment and Supplies (PSC 6640, 3,183 awards) dominate. All identified Remel federal awards carry firm fixed-price pricing on a full-and-open or sole-source basis with no set-aside designations, reflecting its established market position and the specialized, single-source nature of Sensititre equipment and compatible consumables across federal laboratory networks.